SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth

Oncotarget

Volumn 6, Issue 24, 2015, Pages 20711-20722

  Wang, Hai Yan ^a   Lian, Ping ^a   Zheng, Peng Sheng ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Oncogene; P21WAF1 CIP1; SOX9; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN P21; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SOX9; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; SOX9 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C33A CELL LINE; CANCER CELL; CANCER CELL CULTURE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CHEMICAL CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; P21 WAF1/CIP1 GENE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SIHA CELL LINE; SOX9 GENE; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; UPREGULATION; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; ANIMAL; BAGG ALBINO MOUSE; GENETICS; METABOLISM; NUDE MOUSE; ONCOGENE; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; UTERINE CERVIX TUMOR; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; HELA CELLS; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; ONCOGENES; SOX9 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION; UTERINE CERVICAL NEOPLASMS;

EID: 84940213156     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4133     Document Type: Article

References (31)

1. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002; 2:342-350.
2. Jimenez-Wences H, Peralta-Zaragoza O and Fernandez-Tilapa G. Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). Oncol Rep. 2014; 31:2467-2476.
3. Ji J and Zheng PS. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol. 2010; 41:1438-1447.
4. Wu XL and Zheng PS. Undifferentiated embryonic cell transcription factor-1 (UTF1) inhibits the growth of cervical cancer cells by transactivating p27Kip1. Carcinogenesis. 2013; 34:1660-1668.
5. Wang YD, Cai N, Wu XL, Cao HZ, Xie LL and Zheng PS. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway. Cell Death Dis. 2013; 4:e760.
6. Yang WT and Zheng PS. Kruppel-like factor 4 functions as a tumor suppressor in cervical carcinoma. Cancer. 2012; 118:3691-3702.
7. Shukla S, Mahata S, Shishodia G, Pandey A, Tyagi A, Vishnoi K, Basir SF, Das BC and Bharti AC. Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS One. 2013; 8:e67849.
8. Wegner M. All purpose Sox: the many roles of Sox proteins in gene expression. Int J Biochem Cell Biol. 2010.
9. Matheu A, Collado M, Wise C, Manterola L, Cekaite L, Tye AJ, Canamero M, Bujanda L, Schedl A, Cheah KS, Skotheim RI, Lothe RA, Lopez de Munain A, Briscoe J, Serrano M and Lovell-Badge R. Oncogenicity of the developmental transcription factor Sox9. Cancer Res. 2012; 72:1301-1315.
10. Shi G, Sohn KC, Li Z, Choi DK, Park YM, Kim JH, Fan YM, Nam YH, Kim S, Im M, Lee Y, Seo YJ, Kim CD and Lee JH. Expression and functional role of Sox9 in human epidermal keratinocytes. PLoS One. 2013; 8:e54355.
11. Huang ZH, Hurley PJ, Simons BW, Marchionni L, Berman DM, Ross AE and Schaeffer EM. Sox9 is required for prostate development and prostate cancer initiation. Oncotarget. 2012; 3:651-663.
12. Jiang SS, Fang WT, Hou YH, Huang SF, Yen BL, Chang JL, Li SM, Liu HP, Liu YL, Huang CT, Li YW, Jang TH, Chan SH, Yang SJ, Hsiung CA, Wu CW, et al. Upregulation of SOX9 in Lung Adenocarcinoma and Its Involvement in the Regulation of Cell Growth and Tumorigenicity. Clin Cancer Res. 2010; 16:4363-4373.
13. Wang L, He S, Yuan J, Mao X, Cao Y, Zong J, Tu Y and Zhang Y. Oncogenic role of SOX9 expression in human malignant glioma. Med Oncol. 2012; 29:3484-3490.
14. Riemenschnitter C, Teleki I, Tischler V, Guo W and Varga Z. Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy. Springerplus. 2013; 2:695.
15. Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y and Hearing VJ. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest. 2009; 119:954-963.
16. Saegusa M, Hashimura M, Suzuki E, Yoshida T and Kuwata T. Transcriptional Up-Regulation of Sox9 by NF-kappa B in Endometrial Carcinoma Cells, Modulating Cell Proliferation Through Alteration in the p14(ARF)/p53/p21(WAF1) Pathway. Am J Pathol. 2012; 181:684-692.
17. McKay KM, Deavers MT and Prieto VG. Chondroid melanoma metastatic to lung and skin showing SOX-9 expression: a potential diagnostic pitfall. Int J Surg Pathol. 2012; 20:169-172.
18. Wu JH, Liang XA, Wu YM, Li FS and Dai YM. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay. Oncology Reports. 2013; 29:125-132.
19. Kordes U and Hagel C. Expression of SOX9 and SOX10 in central neuroepithelial tumor. J Neurooncol. 2006; 80:151-155.
20. Vidal VP, Ortonne N and Schedl A. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms. J Cutan Pathol. 2008; 35:373-379.
21. Wang H, Leav I, Ibaragi S, Wegner M, Hu GF, Lu ML, Balk SP and Yuan X. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res. 2008; 68:1625-1630.
22. Harris ML, Baxter LL, Loftus SK and Pavan WJ. Sox proteins in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010; 23:496-513.
23. Masuda T, Wahlin K, Wan J, Hu J, Maruotti J, Yang X, Iacovelli J, Wolkow N, Kist R, Dunaief JL, Qian J, Zack DJ and Esumi N. Transcription factor SOX9 plays a key role in the regulation of visual cycle gene expression in the retinal pigment epithelium. J Biol Chem. 2014; 289:12908-12921.
24. Stockl S, Bauer RJ, Bosserhoff AK, Gottl C, Grifka J and Grassel S. Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci. 2013; 126:2890-2902.
25. Kamachi Y, Uchikawa M and Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet. 2000; 16:182-187.
26. Qin GQ, He HC, Han ZD, Liang YX, Yang SB, Huang YQ, Zhou L, Fu H, Li JX, Jiang FN and Zhong WD. Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer. Onco Targets Ther. 2014; 7:137-146.
27. Zhong WD, Qin GQ, Dai QS, Han ZD, Chen SM, Ling XH, Fu X, Cai C, Chen JH, Chen XB, Lin ZY, Deng YH, Wu SL, He HC and Wu CL. SOXs in human prostate cancer: implication as progression and prognosis factors. Bmc Cancer. 2012; 12.
28. Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu XY and Gong LY. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival. J Exp Clin Canc Res. 2012; 31.
29. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3:RESEARCH0034.
30. Clement TM, Bhandari RK, Sadler-Riggleman I and Skinner MK. SRY directly regulates the neurotrophin 3 promoter during male sex determination and testis development in rats. Biol Reprod. 2011; 85:277-284.
31. Bracken AP, Kleine-Kohlbrecher D, Dietrich N, Pasini D, Gargiulo G, Beekman C, Theilgaard-Monch K, Minucci S, Porse BT, Marine JC, Hansen KH and Helin K. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Gene Dev. 2007; 21:525-530.